Category: News

Falchs Fond announces two awards for outstanding researchers in 2026

• Falchs Juniorpris: 100.000 kr i driftsmidler for fremragende forskere under 40 år. Forslag kan fremmes av instituttledere og professorer.
• Falchs Seniorpris. 150.000 kr for fremragende lederskap innen medisinsk forskning. Forslag kan fremmes av instituttledere.

Vennligst se vedlagt utlysningsteks for utfyllende informasjon. – finn ved å trykke «les mer»
The deadline for submitting a nomination is March 5, 2026.

Consultation – Proposed New Act on the Protection Against Infectious Diseases

The Infection Control Act from 1994 is currently under revision. The Helse- og omsorgsdepartementet has conducted a broad and comprehensive review of the Act to ensure that the necessary legal authority is in place to handle potential crisis situations. Experiences from the COVID 19 pandemic have been central to this work, but the Defence Commission, the Civil Protection Act, and the Health Preparedness Report have also provided grounds for changes. Provisions used every day in the country’s municipalities and hospitals have been assessed.

Blood proteins may reveal future risk of heart disease

En ny studie viser at blodet vårt inneholder langt mer informasjon om hjertesykdom enn tidligere antatt. Ved hjelp av avansert dataanalyse har forskere fra blant annet Bergen og Reykjavík kartlagt hvordan hundrevis av blodproteiner samspiller – og hvordan disse mønstrene…

Register for UiB's 3 Minute Thesis competition

The Three Minute Thesis (3MT) is an international research communication competition that challenges PhD candidates to present their research in just three minutes, using a single static slide, to a general audience. The competition was originally developed at the University of Queensland in 2008 and has since grown into an international event, with competitions organised by networks such as the Coimbra Group and SANORD. UiB invites PhD candidates from all disciplines to participate in our internal 3MT competition. The winner will represent UiB in the international finals of the Coimbra Group and SANORD.

Editorial of the week - Kurt Hanevik

Publishing at K2
When the UiB Rector visited K2 last week, she asked about our publication strategy. K2’s strategy is quite simple: We publish open access as much as possible, and when we have strong and very interesting data, we try to publish in so called Level 2 journals. These are the top 20% highest-ranked journals within their field, and the list is updated annually by the National Publication Committee (NPU) and HK-dir. In 2024, 18% of K2’s 422 publications were in Level 2 journals. This is also the average for the Faculty of Medicine. For K2, it should be an objective to exceed 20% in Level 2 publications in order to demonstrate the overall quality of our research. Unfortunately, many Level 2 journals are still not fully open access. We can help promote fully open access Level 2 journals by publishing in them and having publication fees covered by UiB’s

Based on the number of publications, levels, and international collaboration, publication points are calculated. Until 2024, these were used to adjust funding for research institutions in Norway. This is no longer done, but the metric may still be a useful indicator to monitor, considering how well we manage under increasingly tight budget constraints. In the health trusts, publication points will continue to influence funding.

For this statistic to be accurate, it is important that affiliations are written correctly in submitted manuscripts from K2. AI tools often mistranslate this. The correct affiliation, where K2 is the employer or has otherwise contributed to participation in a study, is:

Finally, the K2 leadership congratulates Lars Herfindal, Professor of Pharmacology and the new Head of the Centre for Pharmacy, on receiving the prestigious Olav Thon Foundation Award for Outstanding Teaching.

Friday waffle with Wafflepitch at Eitri

Friday waffle with Wafflepitch at Eitri: Calum Leitch and Irini Ktoridou-Valen: "Repurposing Medicines for Blood Cancer: ValQ and the Bjørgvin Therapeutics Group."

Friday, January 30, 2026

13:00  14:00

Location: Eitri, Haukelandsbakken 31, 5021 Bergen

Despiccable - Misuse of the publication fund

We are fortunate to have a publication fund at UiB that covers article processing charges for fully open access journals. Unfortunately, some individuals have exploited this to mass produce weak articles published in open access journals with poor peer review.

Read the rest of the story by clicking "read more"